We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+13.09%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.3B
AUM Growth
+$1.07B
Cap. Flow
-$113M
Cap. Flow %
-1%
Top 10 Hldgs %
43.92%
Holding
930
New
74
Increased
169
Reduced
352
Closed
28

Top Buys

Rank Stock Value
1
EPD icon
Enterprise Products Partners
EPD
+$37.6M
2
CHPT icon
ChargePoint
CHPT
+$32.5M
3
JNPR
Juniper Networks
JNPR
+$23.3M
4
CEQP
Crestwood Equity Partners LP
CEQP
+$23M
5
SHLS icon
Shoals Technologies Group
SHLS
+$21.9M

Top Sells

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$77.7M
2
NBLX
Noble Midstream Partners LP
NBLX
+$65.5M
3
PAA icon
Plains All American Pipeline
PAA
+$49.7M
4
XRX icon
Xerox
XRX
+$20.9M
5
AYI icon
Acuity Brands
AYI
+$20M

Sector Composition

Rank Sector Weight
1 Energy 52.67%
2 Financials 10.26%
3 Technology 6.92%
4 Healthcare 4.76%
5 Consumer Discretionary 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBFX
901
DELISTED
PBF LOGISTICS LP
PBFX
$191K ﹤0.01%
12,845
+1,702
+15% +$25.9K
NGL icon
902
NGL Energy Partners
NGL
$1.94B
$115K ﹤0.01%
48,380
+7,617
+19% +$17.1K
APRE icon
903
Aprea Therapeutics
APRE
$7.83M
– –
-1,916
Closed -$195K
ARCC icon
904
Ares Capital
ARCC
$13.5B
– –
-72,000
Closed -$1.35M
ASMB icon
905
Assembly Biosciences
ASMB
$506M
– –
-4,979
Closed -$275K
CLDX icon
906
Celldex Therapeutics
CLDX
$2.77B
– –
-71,581
Closed -$1.48M
CVM icon
907
CEL-SCI Corp
CVM
$20.6M
– –
-2,329
Closed -$1.06M
ENOV icon
908
Enovis
ENOV
$1.56B
– –
-18,243
Closed -$1.38M
FATE icon
909
Fate Therapeutics
FATE
$281M
– –
-130,688
Closed -$10.8M
INSM icon
910
Insmed
INSM
$23.2B
– –
-186,428
Closed -$6.35M
IRWD icon
911
Ironwood Pharmaceuticals
IRWD
$611M
– –
-291,213
Closed -$3.26M
KMDA icon
912
Kamada
KMDA
$407M
– –
-80,943
Closed -$501K
NCNA
913
NuCana
NCNA
$5.37M
– –
-19
Closed -$462K
NEU icon
914
NewMarket
NEU
$7.17B
– –
-564
Closed -$214K
PRQR icon
915
ProQR Therapeutics
PRQR
$243M
– –
-90,714
Closed -$600K
QURE icon
916
uniQure
QURE
$2.68B
– –
-81,401
Closed -$2.74M
TARA icon
917
Protara Therapeutics
TARA
$226M
– –
-20,279
Closed -$319K
TCRT icon
918
Alaunos Therapeutics
TCRT
$4.74M
– –
-2,589
Closed -$1.4M
VXRT
919
DELISTED
Vaxart
VXRT
– –
-198,053
Closed -$1.2M
VYGR icon
920
Voyager Therapeutics
VYGR
$187M
– –
-67,782
Closed -$319K
XRX icon
921
Xerox
XRX
$337M
– –
-859,160
Closed -$20.9M
TECX
922
Tectonic Therapeutic
TECX
$573M
– –
-6,250
Closed -$952K
EGRX
923
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– –
-23,570
Closed -$984K
APTX
924
DELISTED
Aptinyx Inc. Common Stock
APTX
– –
-114,443
Closed -$343K
CNCE
925
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-55,449
Closed -$277K
34 35 36
37
38

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, ALPS Advisors held 930 positions worth $11.3B, up 10% from $10.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

ALPS Advisors's Q2 2021 filing shows 74 new, 169 increased, 352 reduced and 28 closed positions. Its largest new stake was ChargePoint: 61,396 shares worth $42.7M. The largest sale was Energy Transfer Partners, an estimated $77.7M.

By sector, the portfolio is most concentrated in Energy at 53% of assets, up from 50% a quarter earlier, followed by Financials and Technology.

  • ALPS Advisors's largest Q2 2021 buy was ChargePoint: 61,396 shares worth $42.7M.
  • ALPS Advisors added most to Enterprise Products Partners in Q2 2021, an estimated $37.6M increase.
  • ALPS Advisors's biggest Q2 2021 reduction was Energy Transfer Partners, cutting an estimated $77.7M.
  • ALPS Advisors fully exited Noble Midstream Partners LP in Q2 2021, selling an estimated $65.5M.
  • ALPS Advisors's ten largest holdings make up 44% of its $11.3B portfolio in Q2 2021.
  • ALPS Advisors opened 74 new positions and closed 28 in Q2 2021.
  • ALPS Advisors's portfolio value rose 10% quarter-over-quarter to $11.3B.

Based on ALPS Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.